Consensus Recommendations for Standardized Data Elements, Scales, and Time Segmentations in Studies of Human Circadian/Diurnal Biology and Stroke.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
07 2023
Historique:
medline: 28 6 2023
pubmed: 5 6 2023
entrez: 5 6 2023
Statut: ppublish

Résumé

Increasing evidence indicates that circadian and diurnal rhythms robustly influence stroke onset, mechanism, progression, recovery, and response to therapy in human patients. Pioneering initial investigations yielded important insights but were often single-center series, used basic imaging approaches, and used conflicting definitions of key data elements, including what constitutes daytime versus nighttime. Contemporary methodologic advances in human neurovascular investigation have the potential to substantially increase understanding, including the use of large multicenter and national data registries, detailed clinical trial data sets, analysis guided by individual patient chronotype, and multimodal computed tomographic and magnetic resonance imaging. To fully harness the power of these approaches to enhance pathophysiologic knowledge, an important foundational step is to develop standardized definitions and coding guides for data collection, permitting rapid aggregation of data acquired in different studies, and ensuring a common framework for analysis. To meet this need, the Leducq Consortium International pour la Recherche Circadienne sur l'AVC (CIRCA) convened a Consensus Statement Working Group of leading international researchers in cerebrovascular and circadian/diurnal biology. Using an iterative, mixed-methods process, the working group developed 79 data standards, including 48 common data elements (23 new and 25 modified/unmodified from existing common data elements), 14 intervals for time-anchored analyses of different granularity, and 7 formal, validated scales. This portfolio of standardized data structures is now available to assist researchers in the design, implementation, aggregation, and interpretation of clinical, imaging, and population research related to the influence of human circadian/diurnal biology upon ischemic and hemorrhagic stroke.

Identifiants

pubmed: 37272394
doi: 10.1161/STROKEAHA.122.041394
doi:

Types de publication

Journal Article Review Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1943-1949

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS099055
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS099055
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS114001
Pays : United States
Organisme : NIA NIH HHS
ID : U54 AG062322
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS114526
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK102624
Pays : United States
Organisme : NIDA NIH HHS
ID : R21 DA052861
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS067139
Pays : United States

Auteurs

Jeffrey L Saver (JL)

Department of Neurology and Comprehensive Stroke Center, Geffen School of Medicine, University of Los Angeles, CA (J.L.S., M.B.-H., D.S.L., K.T.M., E.M.S.).

Elizabeth B Klerman (EB)

Department of Neurology, Cardio-Neurology Division, Massachusetts General Hospital (E.B.K., M.N.), Harvard Medical School, Boston.
Division of Sleep Medicine (E.B.K.), Harvard Medical School, Boston.

Alastair M Buchan (AM)

Acute Stroke Programme, Radcliffe Department of Medicine (A.M.B., P.M.), University of Oxford, United Kingdom.

Patricia Calleja (P)

Department of Neurology and Stroke Center, Doce de Octubre University Hospital (P.C.), Complutense Medical School, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.

Ignacio Lizasoain (I)

Department of Pharmacology and Toxicology (I.L.), Complutense Medical School, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.

Mersedeh Bahr-Hosseini (M)

Department of Neurology and Comprehensive Stroke Center, Geffen School of Medicine, University of Los Angeles, CA (J.L.S., M.B.-H., D.S.L., K.T.M., E.M.S.).

Sarah Lee (S)

Department of Neurology, Stanford University, Palo Alto, CA (S.L., P.S., A.S., G.W.A.).

David S Liebeskind (DS)

Department of Neurology and Comprehensive Stroke Center, Geffen School of Medicine, University of Los Angeles, CA (J.L.S., M.B.-H., D.S.L., K.T.M., E.M.S.).

Philipp Mergenthaler (P)

Acute Stroke Programme, Radcliffe Department of Medicine (A.M.B., P.M.), University of Oxford, United Kingdom.
Center for Stroke Research Berlin (P.M.), Charité-Universitätsmedizin Berlin, Germany.
Department of Neurology With Experimental Neurology, Clinical Research Center (P.M.), Charité-Universitätsmedizin Berlin, Germany.

Katherine T Mun (KT)

Department of Neurology and Comprehensive Stroke Center, Geffen School of Medicine, University of Los Angeles, CA (J.L.S., M.B.-H., D.S.L., K.T.M., E.M.S.).

MingMing Ning (M)

Department of Neurology, Cardio-Neurology Division, Massachusetts General Hospital (E.B.K., M.N.), Harvard Medical School, Boston.

David Pelz (D)

Departments of Medical Imaging and Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada (D.P.).

David Ray (D)

Oxford Centre for Diabetes, Endocrinology and Metabolism, and Oxford Kavli Centre for Nanoscience Discovery, Radcliffe Department of Medicine (D.R.), University of Oxford, United Kingdom.

Peter M Rothwell (PM)

Wolfson Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences (P.M.R., A.J.S.W.), University of Oxford, United Kingdom.

Pierre Seners (P)

Department of Neurology, Stanford University, Palo Alto, CA (S.L., P.S., A.S., G.W.A.).
Neurology Department, Hôpital Fondation A. de Rothschild, Institut de Psychiatrie et Neurosciences de Paris, UMR_S1266, INSERM, Université de Paris, France (P.S.).

Anirudh Sreekrishnan (A)

Department of Neurology, Stanford University, Palo Alto, CA (S.L., P.S., A.S., G.W.A.).

Eleanor Mina Sung (EM)

Department of Neurology and Comprehensive Stroke Center, Geffen School of Medicine, University of Los Angeles, CA (J.L.S., M.B.-H., D.S.L., K.T.M., E.M.S.).

Steffen Tiedt (S)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Germany (S.T., T.A.W.).

Alastair J S Webb (AJS)

Wolfson Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences (P.M.R., A.J.S.W.), University of Oxford, United Kingdom.

Teresa A Wölfer (TA)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Germany (S.T., T.A.W.).

Gregory W Albers (GW)

Department of Neurology, Stanford University, Palo Alto, CA (S.L., P.S., A.S., G.W.A.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH